Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Feehan, Michael ^a   Hartman, John ^a   Durante, Richard ^a   Morrison, Margaux A ^b,c   Miller, Joan W ^b   Kim, Ivana K ^b   DeAngelis, Margaret M ^b,c  

^a Observant LLC   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; HTRA SERINE PEPTIDASE 1; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG; ARMS2 PROTEIN, HUMAN; HTRA1 PROTEIN, HUMAN; PROTEIN; SERINE PROTEINASE;

AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 10Q; CHROMOSOME 1Q; CIGARETTE SMOKING; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEALTH STATUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RETINA MACULA AGE RELATED DEGENERATION; BODY MASS; CHROMOSOME 10; CLASSIFICATION; CLUSTER ANALYSIS; DRINKING BEHAVIOR; GENETICS; GENOTYPE; PHENOTYPE; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ALLELES; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 10; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MACULAR DEGENERATION; MALE; PHENOTYPE; PROTEINS; RETINAL NEOVASCULARIZATION; RISK FACTORS; SERINE ENDOPEPTIDASES; SMOKING;

EID: 79958846532     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-83     Document Type: Article

References (73)

1. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009, 461:724-726. 10.1038/461724a, 19812653.
2. Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE. Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 2009, 5:e1000337. 10.1371/journal.pgen.1000337, 2629574, 19197355.
3. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008, 358:2606-2617. 10.1056/NEJMra0801537, 18550876.
4. Klein R, Deng Y, Klein BEK, Hyman L, Seddon J, Frank RN, Wallace RB, Hendrix SL, Kuppermann BD, Langer RD, Kuller L, Brunner R, Johnson KC, Thomas AM, Haan M. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol 2007, 143:473-483. 10.1016/j.ajo.2006.11.058, 2812860, 17317391.
5. Baird PN, Hageman GS, Guymer RH. New era for personalized medicine: the diagnosis and management of age-related macular degeneration. Clin Experiment Ophthalmol 2009, 37:814-821. 10.1111/j.1442-9071.2009.02136.x, 19878229.
6. Chaine G, Hullo A, Sahel J, Soubrane G, Espinasse-Berrod MA, Schutz D, Bourguignon C, Harpey C, Brault Y, Coste M, Moccatti D, Bourgeois H. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 1998, 82:996-1002. 10.1136/bjo.82.9.996, 1722735, 9893587.
7. Klein R, Klein BEK, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 2002, 156:589-598. 10.1093/aje/kwf092, 12244027.
8. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992, 99:933-943.
9. Wong TY, Tikellis G, Sun C, Klein R, Couper DJ, Sharrett AR. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Ophthalmology 2007, 114:86-91. 10.1016/j.ophtha.2006.06.039, 17198851.
10. Nguyen-Khoa BA, Goehring EL, Werther W, Gower EW, Do DV, Jones JK. Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 2008, 126:1280-1286. 10.1001/archopht.126.9.1280, 18779491.
11. McCarty CA, Dowrick A, Cameron J, McGrath B, Robman LD, Dimitrov P, Tikellis G, Nicolas C, McNeil J, Guymer R. Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM Study. BMC Ophthalmol 2008, 8:25. 10.1186/1471-2415-8-25, 2627823, 19102747.
12. Sun C, Klein R, Wong TY. Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. Ophthalmology 2009, 116:1913-1919. 10.1016/j.ophtha.2009.03.046, 19592102.
13. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye (Lond) 2005, 19:935-944.
14. Cong R, Zhou B, Sun Q, Gu H, Tang N, Wang B. Smoking and the risk of age-related macular degeneration: a meta-analysis. Ann Epidemiol 2008, 18:647-656. 10.1016/j.annepidem.2008.04.002, 18652983.
15. Ajani UA, Christen WG, Manson JE, Glynn RJ, Schaumberg D, Buring JE, Hennekens CH. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol 1999, 9:172-177. 10.1016/S1047-2797(98)00053-2, 10192649.
16. Cho E, Hankinson SE, Willett WC, Stampfer MJ, Spiegelman D, Speizer FE, Rimm EB, Seddon JM. Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 2000, 118:681-688.
17. DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 2004, 122:575-580. 10.1001/archopht.122.4.575, 15078676.
18. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003, 121:785-792. 10.1001/archopht.121.6.785, 12796248.
19. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000, 107:2224-2232. 1470467, 11097601.
20. Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol 2007, 52:180-195. 10.1016/j.survophthal.2006.12.003, 2698026, 17355856.
21. Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997, 104:1804-1812.
22. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000, 14:835-846.
23. Baker ML, Wang JJ, Rogers S, Klein R, Kuller LH, Larsen EK, Wong TY. Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch Ophthalmol 2009, 127:667-673. 10.1001/archophthalmol.2009.30, 3001290, 19433718.
24. Tan JSL, Wang JJ, Flood V, Mitchell P. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol 2009, 127:656-665. 10.1001/archophthalmol.2009.76, 19433717.
25. Yu AL, Lorenz RL, Haritoglou C, Kampik A, Welge-Lussen U. Biological effects of native and oxidized low-density lipoproteins in cultured human retinal pigment epithelial cells. Exp Eye Res 2009, 88:495-503. 10.1016/j.exer.2008.10.028, 19071111.
26. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BEK, Gotoh N, Yamashiro K, Ferris Iii F, Fagerness JA, Reynolds R, Farrer LA, Kim IK, Miller JW, Cortón M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, Deangelis MM, Weeks DE, Zack DJ, Chew EY, Heckenlively JR, Yoshimura N, Iyengar SK, Francis PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010, 107:7401-7406. 10.1073/pnas.0912702107, 2867722, 20385819.
27. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, Bernstein PS, Li B, Frederick JM, Zhang K, Brantley MA, Lee AY, Zack DJ, Campochiaro B, Campochiaro P, Ripke S, Smith RT, Barile GR, Katsanis N, Allikmets R, Daly MJ, Seddon JM. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010, 107:7395-7400. 10.1073/pnas.0912019107, 2867697, 20385826.
28. Silveira AC, Morrison MA, Ji F, Xu H, Reinecke JB, Adams SM, Arneberg TM, Janssian M, Lee JE, Yuan Y, Schaumberg DA, Kotoula MG, Tsironi EE, Tsiloulis AN, Chatzoulis DZ, Miller JW, Kim IK, Hageman GS, Farrer LA, Haider NB, DeAngelis MM. Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res 2010, 50:698-715. 10.1016/j.visres.2009.09.016, 2884392, 19786043.
29. Schaumberg DA, Chasman D, Morrison MA, Adams SM, Guo Q, Hunter DJ, Hankinson SE, DeAngelis MM. Prospective study of common variants in the retinoic acid receptor-related orphan receptor α gene and risk of neovascular age-related macular degeneration. Arch Ophthalmol 2010, 128:1462-1471. 10.1001/archophthalmol.2010.261, 21060049.
30. Yamada Y, Tian J, Yang Y, Cutler RG, Wu T, Telljohann RS, Mattson MP, Handa JT. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J Neurochem 2008, 105:1187-1197. 10.1111/j.1471-4159.2008.05211.x, 18182060.
31. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009, 28:1-18. 10.1016/j.preteyeres.2008.10.001, 2715284, 19026761.
32. Sallo FB, Bereczki E, Csont T, Luthert PJ, Munro P, Ferdinandy P, Sántha M, Lengyel I. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes. Exp Eye Res 2009, 89:178-186. 10.1016/j.exer.2009.03.006, 19324038.
33. Wilson HL, Schwartz DM, Bhatt HRF, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol 2004, 137:615-624.
34. McGwin G, Xie A, Owsley C. The use of cholesterol-lowering medications and age-related macular degeneration. Ophthalmology 2005, 112:488-494. 10.1016/j.ophtha.2004.10.027, 15745779.
35. Klein R, Klein BEK, Tomany SC, Danforth LG, Cruickshanks KJ. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch Ophthalmol 2003, 121:1151-1155. 10.1001/archopht.121.8.1151, 12912693.
36. van Leeuwen R, Vingerling JR, Hofman A, de Jong PTVM, Stricker BHC. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003, 326:255-256. 140763, 12560276.
37. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000, 118:351-358.
38. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001, 108:697-704. 10.1016/S0161-6420(00)00580-7, 11297486.
39. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424. 10.1126/science.1110189, 15761121.
40. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJH, Silvestri G, Russell SR, Klaver CCW, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005, 102:7227-7232. 10.1073/pnas.0501536102, 1088171, 15870199.
41. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421. 10.1126/science.1110359, 15761120.
42. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389. 10.1126/science.1109557, 1512523, 15761122.
43. Zareparsi S, Branham KEH, Li M, Shah S, Klein RJ, Ott J, Hoh J, Abecasis GR, Swaroop A. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005, 77:149-153. 10.1086/431426, 1226187, 15895326.
44. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005, 77:389-407. 10.1086/444437, 1226205, 16080115.
45. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, Weber BHF. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005, 14:3227-3236. 10.1093/hmg/ddi353, 16174643.
46. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L, Ferrell RE, Gorin MB. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006, 15:3206-3218. 10.1093/hmg/ddl396, 17000705.
47. Dewan A, Liu M, Hartman S, Zhang SS-M, Liu DTL, Zhao C, Tam POS, Chan WM, Lam DSC, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314:989-992. 10.1126/science.1133807, 17053108.
48. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314:992-993. 10.1126/science.1133811, 17053109.
49. Deangelis MM, Ji F, Adams S, Morrison MA, Harring AJ, Sweeney MO, Capone A, Miller JW, Dryja TP, Ott J, Kim IK. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 2008, 115:1209-1215.e7. 10.1016/j.ophtha.2007.10.032, 18164066.
50. DeAngelis MM, Ji F, Kim IK, Adams S, Capone A, Ott J, Miller JW, Dryja TP. Cigarette smoking, CFH, APOE, ELOVL4, and risk of neovascular age-related macular degeneration. Arch Ophthalmol 2007, 125:49-54. 10.1001/archopht.125.1.49, 17210851.
51. Baird PN, Robman LD, Richardson AJ, Dimitrov PN, Tikellis G, McCarty CA, Guymer RH. Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. Hum Mol Genet 2008, 17:1299-1305. 10.1093/hmg/ddn018, 18203751.
52. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P, Wong F, Chen YS, Spencer K, Schnetz-Boutaud N, Haines JL, Pericak-Vance MA. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006, 78:852-864. 10.1086/503822, 1474047, 16642439.
53. Tan JSL, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007, 114:1143-1150. 10.1016/j.ophtha.2006.09.033, 17275090.
54. Hogg RE, Woodside JV, Gilchrist SECM, Graydon R, Fletcher AE, Chan W, Knox A, Cartmill B, Chakravarthy U. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008, 115:1046-1052.e2. 10.1016/j.ophtha.2007.07.031, 17953990.
55. Ellis TE, Rudd MD, Rajab MH, Wehrly TE. Cluster analysis of MCMI scores of suicidal psychiatric patients: four personality profiles. J Clin Psychol 1996, 52:411-422. 10.1002/(SICI)1097-4679(199607)52:4<411::AID-JCLP5>3.0.CO;2-S, 8842877.
56. Quirk SW, McCormick RA. Personality subtypes, coping styles, symptom correlates, and substances of choice among a cohort of substance abusers. Assessment 1998, 5:157-169. 10.1177/107319119800500206, 9626391.
57. van Rooden SM, Colas F, Martínez-Martín P, Visser M, Verbaan D, Marinus J, Chaudhuri RK, Kok JN, van Hilten JJ. Clinical subtypes of Parkinson's disease. Mov Disord 2010,
58. Jáuregui Lobera I, Garrido O, Santiago Fernández MJ, Alvarez Bautista E. Social comparison as a coping strategy among caregivers of eating disorder patients. J Psychiatr Ment Health Nurs 2010, 17:775-782. 10.1111/j.1365-2850.2010.01611.x, 21040222.
59. Zhang H, Morrison MA, Dewan A, Adams S, Andreoli M, Huynh N, Regan M, Brown A, Miller JW, Kim IK, Hoh J, Deangelis MM. The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration. BMC Med Genet 2008, 9:51. 2441616, 18541031.
60. Andreoli MT, Morrison MA, Kim BJ, Chen L, Adams SM, Miller JW, DeAngelis MM, Kim IK. Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration. Am J Ophthalmol 2009, 148:869-874. 10.1016/j.ajo.2009.07.002, 2787659, 19796758.
61. Jardine N, Sibson R. Mathematical Taxonomy 1971, John Wiley & Sons Ltd.
62. Winkel P, Paldam M, Tygstrup N. A numerical taxonomic analysis of symptoms and signs in 400 patients with cirrhosis of the liver. Comput Biomed Res 1970, 3:657-665. 10.1016/0010-4809(70)90033-9, 5508349.
63. Bozinov D, Rahnenführer J. Unsupervised technique for robust target separation and analysis of DNA microarray spots through adaptive pixel clustering. Bioinformatics 2002, 18:747-756. 10.1093/bioinformatics/18.5.747, 12050071.
64. Yang YH, Buckley MJ, Dudoit S, Speed TP. Comparison of Methods for Image Analysis on cDNA Microarray Data. Journal of Computational and Graphical Statistics 2002, 11:108-136.
65. Jakobsson M, Scholz SW, Scheet P, Gibbs JR, VanLiere JM, Fung HC, Szpiech ZA, Degnan JH, Wang K, Guerreiro R, Bras JM, Schymick JC, Hernandez DG, Traynor BJ, Simon-Sanchez J, Matarin M, Britton A, van de Leemput J, Rafferty I, Bucan M, Cann HM, Hardy JA, Rosenberg NA, Singleton AB. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 2008, 451:998-1003. 10.1038/nature06742, 18288195.
66. Phipps A, Hubert L. Cluster analysis in marketing research. Advanced Methods of Marketing Research 1994, 160-189. Wiley.
67. Wedel M. Market segment derivation and profiling via a finite mixture model framework. Marketing Letters 2002, 13:17-25.
68. Wedel M, Kamakura WA. Market Segmentation: Conceptual and Methodological Foundations 2000, Kluwer Academic Publishers, 2.
69. Punj G, Stewart DW. Cluster Analysis in Marketing Research: Review and Suggestions for Application. Journal of Marketing Research 1983, 20:134-148.
70. Zhang T, Ramakrishnon R, Livny M. BIRCH: An efficient data clustering method for very large databases. 1996,
71. Sneath PHA. Numerical Taxonomy: The Principles and Practice of Numerical Classification 1973, W H Freeman & Co (Sd).
72. Han K, Kim S, Narayanan S. Strategies to Improve the Robustness of Agglomerative Hierarchical Clustering Under Data Source Variation for Speaker Diarization. Audio, Speech, and Language Processing, IEEE Transactions 2008, 16:1590-1601.
73. Enseleit F, Michels S, Ruschitzka F. Anti-VEGF therapies and blood pressure: more than meets the eye. Curr Hypertens Rep 2010, 12:33-38. 10.1007/s11906-009-0082-x, 20425156.